Evaluation of Prospective<i>HLA-B*13:01</i>Screening to Prevent Dapsone Hypersensitivity Syndrome in Patients With Leprosy
Dapsone hypersensitivity syndrome (DHS) is the most serious adverse reaction associated with dapsone administration and one of the major causes of death in patients with leprosy, whose standard treatment includes multidrug therapy (MDT) with dapsone, rifampicin, and clofazimine. Although the HLA-B*1...
Uloženo v:
Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Médium: | Artigo |
Jazyk: | angličtina |
Vydáno: |
2019
|
On-line přístup: | https://doi.org/10.1001/jamadermatol.2018.5360 https://jamanetwork.com/journals/jamadermatology/articlepdf/2729073/jamadermatology_liu_2019_oi_180083.pdf |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|